Processa Pharmaceuticals Inc.

06/10/2021 | Press release | Distributed by Public on 06/10/2021 15:30

Submission of Matters to a Vote of Security Holders (Form 8-K)

Submission of Matters to a Vote of Security Holders.

On June 8, 2021, the Company held its Annual Meeting of Shareholders. The Shareholders voted on five proposals and cast their votes as follows:

1. All five directors were elected to serve until the next Annual Meeting of Shareholders or until their successors have been duly elected and qualified based on the following votes:
Shares
Name For Against Abstain Broker Non-Votes
Dr. David Young 11,014,321 7,905 - 1,975,184
Dr. Khalid Islam 10,950,970 71,256 - 1,975,184
Geraldine Pannu 11,011,123 11,103 - 1,975,184
Virgil Thompson 10,899,514 122,712 - 1,975,184
Justin Yorke 10,854,402 167,824 - 1,975,184
2. Results of the advisory vote relating to compensation of our named executive officers were as follows:
Shares
For Against Abstain Broker Non-Votes
11,011,750 7,831 2,645 1,975,184
3. Results of the advisory vote on the frequency of future advisory votes on executive compensation are below. In accordance with voting results, the Company will conduct an advisory vote on executive compensation every year.
Shares
1 Year 2 Years 3 Years Abstain Broker Non-Votes
10,186,391 673,622 70,032 92,181 1,975,184
4. The amendment and restatement of the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan to increase the number of shares available for issuance under the Plan by 2,500,000 was approved based on the following votes:
Shares
For Against Abstain Broker Non-Votes
10,509,052 9,979 503,195 1,975,184
5. The appointment of BD & Company Inc. as the independent registered public accounting firm 2021 was ratified based on the following votes.
Shares
For Against Abstain

Broker

Non-Votes

12,467,390 259,759 270,261 -